The PBS has published its latest list of medicines set to undergo price disclosure reductions
These medicines are part of the Fifth Remove Originator price reduction cycle, set to take place on 1 October 2018.
Among the medications affected in this cycle are:
- Valsartan with hydrochlorothiazide
Indicative prices for 1 October 2018 (including price to pharmacy, dispensed price for maximum quantity and price premiums) will be published by early July 2018.
Click here to see the full list, plus background information